- Title
- Endogenous Nitric Oxide Synthase Inhibitors, Arterial Hemodynamics, and Subclinical Vascular Disease : The PREVENCION Study
- Creators
- Julio A CHIRINOS - University of Pennsylvania, Philadelphia, United StatesRobert DAVID - Metametrix Clinical Laboratory, Duluth, Ga, United StatesJ. Alexander BRALLEY - Metametrix Clinical Laboratory, Duluth, Ga, United StatesHumberto ZEA-DFAZ - Santa Maria Catholic University School of Medicine, AQP, PeruEdgar MUNOZ-ATAHUALPA - Santa Maria Catholic University School of Medicine, AQP, PeruFernando CORRALES-MEDINA - Santa Maria Catholic University School of Medicine, AQP, PeruCarolina CUBA-BUSTINZA - Santa Maria Catholic University School of Medicine, AQP, PeruJulio CHIRINOS-PACHECO - Santa Maria Catholic University School of Medicine, AQP, PeruJosefina MEDINA-LEZAMA - Santa Maria Catholic University School of Medicine, AQP, Peru
- Publication Details
- Hypertension (Dallas, Tex. 1979), Vol.52(6), pp.1051-1059
- Publisher
- Lippincott Williams & Wilkins
- Academic Unit
- Miller School of Medicine; UMMG Department of Pediatrics; UMMG Dept of Pediatrics - Hematology/Oncology/Stem Cell Transp
- Language
- English
- Resource Type
- Journal article
- PMID
- 18852383
- Record Identifier
- 991031600338602976
Journal article
Endogenous Nitric Oxide Synthase Inhibitors, Arterial Hemodynamics, and Subclinical Vascular Disease : The PREVENCION Study
Hypertension (Dallas, Tex. 1979), Vol.52(6), pp.1051-1059
2008
PMID: 18852383
Metrics
5 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.127 Molecular & Cell Biology - Pharmacology
- 1.127.87 Nitric Oxide
- Web Of Science research areas
- Peripheral Vascular Disease
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites